|
Hongjun Wang PhD
Professor
Medical University of South Carolina
USA
|
Her research is focused on using anti-inflammatory approaches to target osteoarthritis (OA), including i) using proprietary enhanced mesenchymal stromal cells (MSCs), and ii) reprograming monocytes/macrophages to more inflammation resolving subtypes using small molecules and gene edited iPSCs. Dr. Viswanathan is a co-Principal Investigator of a recently completed trial using autologous MSCs to treat OA patients, a North American first. Dr. Viswanathan’s publication was cited as the most downloaded paper in Stem Cells Translational Medicine in 2019 and garnered The Arthritis Society’s (TAS) Top 10 Research Advances in 2019.